From: New GOLD classification: longitudinal data on group assignment
GOLD 2013 | |||||
---|---|---|---|---|---|
Variable | A | B | C | D | p |
Gender (M/F)* | 125 / 22 | 255 / 59 | 35 / 5 | 272 / 55 | 0.632 |
Age | 66 (8) | 68 (9) | 68 (9) | 68 (9) | 0.030 |
Pack-yr | 50 (24) | 55 (27) | 51 (28) | 60 (29) | 0.006 |
Active smoking* | 40% | 38% | 28% | 25% | 0.001 |
BMI (kg/m2) | 27.9 (4.7) | 28.7 (6.2) | 27.6 (4.6) | 27.9 (5.1) | 0.155 |
6MWD m | 474 (97) | 450 (98) | 428 (93) | 400 (108) | <0.001 |
BODE index † | 0 (0-2) | 1 (0-4) | 2 (0-7) | 3 (0-7) | <0.001 |
Charlson index † | 1 (0-5) | 1 (0-5) | 1 (0-4) | 1 (0-5) | 0.263 |
Inhaled anti cholinergic* | 56% | 68% | 87% | 88% | <0.001 |
Inhaled β2-agonist* | 53% | 68% | 88% | 90% | <0.001 |
Inhaled corticosteroid* | 45% | 55% | 82% | 83% | <0.001 |
Theophylline* | 0.7% | 5% | 10% | 17% | <0.001 |